Top Pharmaceuticals companies in Canada by Receivables

This ranking features the top 31 Pharmaceuticals companies in Canada ranked by Receivables, totalling a Receivables of USD 7.72 B, for January 15, 2025.

Canada

Pharmaceuticals

#	Name	Receivables	Reported Date	Stock Price	Change	Country
1	Loblaw Companies Limited 1 L.TO	USD 4.10 B	Dec. 31, 2023	USD 122.81	-2.58%	Canada
2	Bausch Health Companies Inc. 2 BHC.TO	USD 2.00 B	Dec. 31, 2023	USD 7.49	1.16%	Canada
3	Bausch + Lomb Corporation 3 BLCO.TO	USD 839.00 M	Dec. 31, 2023	USD 17.23	-0.99%	Canada
4	Jamieson Wellness Inc. 4 JWEL.TO	USD 124.11 M	Dec. 31, 2023	USD 23.94	0.98%	Canada
5	Tilray Brands, Inc. 5 TLRY.TO	USD 101.69 M	May 31, 2024	USD 1.18	-0.37%	Canada
6	Savaria Corporation 6 SIS.TO	USD 88.63 M	Dec. 31, 2023	USD 13.41	0.42%	Canada
7	Andlauer Healthcare Group Inc. 7 AND.TO	USD 78.04 M	Dec. 31, 2023	USD 30.84	0.81%	Canada
8	Knight Therapeutics Inc. 8 GUD.TO	USD 74.11 M	Dec. 31, 2023	USD 3.69	0.40%	Canada
9	AbCellera Biologics Inc. 9 ABCL	USD 64.38 M	Dec. 31, 2023	USD 2.77	-7.67%	Canada
10	Canopy Growth Corporation 10 WEED.TO	USD 38.27 M	March 31, 2024	USD 2.23	-6.78%	Canada
11	Aurora Cannabis Inc. 11 ACB.TO	USD 33.52 M	March 31, 2024	USD 3.94	-2.21%	Canada
12	CareRx Corporation 12 CRRX.TO	USD 27.23 M	Dec. 31, 2023	USD 1.51	-0.70%	Canada
13	OrganiGram Holdings Inc. 13 OGI.TO	USD 27.08 M	Sept. 30, 2024	USD 1.53	-2.45%	Canada
14	Aurinia Pharmaceuticals Inc. 14 AUPH	USD 24.09 M	Dec. 31, 2023	USD 7.55	-2.83%	Canada
15	Medexus Pharmaceuticals Inc. 15 MDP.TO	USD 24.03 M	March 31, 2024	USD 3.11	5.40%	Canada
16	Zymeworks Inc. 16 ZYME	USD 19.48 M	Dec. 31, 2023	USD 13.62	-2.44%	Canada
17	Repare Therapeutics Inc. 17 RPTX	USD 15.31 M	Dec. 31, 2023	USD 1.27	-3.05%	Canada
18	Theratechnologies Inc. 18 TH.TO	USD 12.80 M	Nov. 30, 2023	USD 1.71	4.46%	Canada
19	HLS Therapeutics Inc. 19 HLS.TO	USD 10.69 M	Dec. 31, 2023	USD 2.70	2.33%	Canada
20	Profound Medical Corp. 20 PRN.TO	USD 7.29 M	Dec. 31, 2023	USD 7.26	-2.32%	Canada
21	Flora Growth Corp. 21 FLGC	USD 7.10 M	Dec. 31, 2023	USD 0.94	1.68%	Canada
22	Cipher Pharmaceuticals Inc. 22 CPH.TO	USD 5.09 M	Dec. 31, 2023	USD 9.40	-4.39%	Canada
23	Sunshine Biopharma, Inc. 23 SBFM	USD 2.55 M	Dec. 31, 2023	USD 2.82	-2.42%	Canada
24	Xenon Pharmaceuticals Inc. 24 XENE	USD 874.00 K	Dec. 31, 2023	USD 39.65	3.66%	Canada
25	Edesa Biotech, Inc. 25 EDSA	USD 626.54 K	Sept. 30, 2023	USD 1.59	-8.09%	Canada
26	InMed Pharmaceuticals Inc. 26 INM	USD 352.84 K	June 30, 2024	USD 4.08	-3.32%	Canada
27	Lexaria Bioscience Corp. 27 LEXX	USD 154.48 K	Aug. 31, 2024	USD 1.93	-6.31%	Canada
28	Achieve Life Sciences, Inc. 28 ACHV	USD 111.00 K	Dec. 31, 2023	USD 3.15	-5.12%	Canada
29	XORTX Therapeutics Inc. 29 XRTX.V	USD 60.71 K	Dec. 31, 2023	USD 1.25	-0.34%	Canada
30	enGene Holdings Inc. Common Stock 30 ENGN	USD 0.00	Oct. 31, 2024	USD 7.58	-5.96%	Canada
31	Clearmind Medicine Inc. 31 CMND	USD 0.00	Oct. 31, 2023	USD 1.51	-1.31%	Canada

Frequently Asked Questions

Which Pharmaceuticals company in Canada has the highest Receivables ?

The Pharmaceuticals company in Canada with the highest Receivables is Loblaw Companies Limited (Toronto Stock Exchange: L.TO) at USD 4.10 B.
Which Pharmaceuticals company in Canada has the lowest Receivables ?

The Pharmaceuticals company in Canada with the lowest Receivables is Clearmind Medicine Inc. (NasdaqCM: CMND) at USD 0.00.

What are the top 10 Pharmaceuticals companies in Canada by Receivables ?

The top 10 Pharmaceuticals companies in Canada by Receivables are Loblaw Companies Limited, Bausch Health Companies Inc., Bausch + Lomb Corporation, Jamieson Wellness Inc., Tilray Brands, Inc., Savaria Corporation, Andlauer Healthcare Group Inc., Knight Therapeutics Inc., AbCellera Biologics Inc. and Canopy Growth Corporation.
What are the bottom 10 Pharmaceuticals companies in Canada by Receivables ?

The bottom 10 Pharmaceuticals companies in Canada by Receivables are Clearmind Medicine Inc., enGene Holdings Inc. Common Stock, XORTX Therapeutics Inc., Achieve Life Sciences, Inc., Lexaria Bioscience Corp., InMed Pharmaceuticals Inc., Edesa Biotech, Inc., Xenon Pharmaceuticals Inc., Sunshine Biopharma, Inc. and Cipher Pharmaceuticals Inc..